BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
830 results:

  • 1. Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.
    Karihtala P; Leivonen SK; Puistola U; Urpilainen E; Jääskeläinen A; Leppä S; Jukkola A
    Breast Cancer Res; 2024 Apr; 26(1):61. PubMed ID: 38594742
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Outcomes of the patients with metastatic male breast cancer.
    Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
    J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genome-wide analyses reveal the regulatory roles of DNA methylation-regulated alternative promoter transcripts in breast cancer.
    Song Y; Shen T; Sun H; Wang X
    Hum Genet; 2024 Mar; 143(3):385-399. PubMed ID: 38502355
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
    Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
    ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Timing of Administration of Pegfilgrastim and Prophylaxis for Febrile Neutropenia for Patients with Early breast cancer Receiving Chemotherapy].
    Toyoda C; Mizuno Y
    Gan To Kagaku Ryoho; 2024 Feb; 51(2):149-152. PubMed ID: 38449400
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies.
    Wen H; Deng G; Shi X; Liu Z; Lin A; Cheng Q; Zhang J; Luo P
    ESMO Open; 2024 Mar; 9(3):102241. PubMed ID: 38442453
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers.
    Cao Y; Xiong J; Du Y; Tang Y; Yin L
    Lasers Med Sci; 2024 Feb; 39(1):68. PubMed ID: 38374512
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Knowledge of breast cancer, willingness and barriers to mammography screening among rural women in Enugu State, Nigeria.
    Abugu LI; Nwagu EN; Okeke AI; Odo AN
    Afr Health Sci; 2023 Sep; 23(3):280-290. PubMed ID: 38357180
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy.
    Kim MW; Lee H; Lee S; Moon S; Kim Y; Kim JY; Kim SI; Kim JY
    BMC Cancer; 2024 Feb; 24(1):185. PubMed ID: 38326737
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effect of Paxillin Expression and Phosphorylation on Colorectal cancer prognosis and Metastasis.
    Zheng H; Tsunedomi R; Xu M; Zhang Y; Kishi H; Kobayashi S; Tomochika S; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Iida M; Ioka T; Nagano H
    Anticancer Res; 2024 Feb; 44(2):511-520. PubMed ID: 38307570
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Investigation of Genetic Alterations Associated With Interval breast cancer.
    Rodriguez J; Grassmann F; Xiao Q; Eriksson M; Mao X; Bajalica-Lagercrantz S; Hall P; Czene K
    JAMA Oncol; 2024 Mar; 10(3):372-379. PubMed ID: 38270937
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
    Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
    Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
    Fuentes C; Ouldbey Y; Orbach D; Sudour-Bonnange H; Verité C; Rome A; Dumesnil C; Thebaud E; Hameury F; Dijoud F; Chabaud S; Cote MD; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30864. PubMed ID: 38259036
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluating the clinical performance of
    Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W
    Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. N-glycan profiling of tissue samples to aid breast cancer subtyping.
    Benesova I; Nenutil R; Urminsky A; Lattova E; Uhrik L; Grell P; Kokas FZ; Halamkova J; Zdrahal Z; Vojtesek B; Novotny MV; Hernychova L
    Sci Rep; 2024 Jan; 14(1):320. PubMed ID: 38172220
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Estrogen receptor beta suppresses the androgen receptor oncogenic effects in triple-negative breast cancer.
    Xu F; Xu K; Fan L; Li X; Liu Y; Yang F; Zhu C; Guan X
    Chin Med J (Engl); 2024 Feb; 137(3):338-349. PubMed ID: 38105538
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database.
    Tang LS; Zhou YW; Wang JL; Zhang GX; Xu CH; Liu JY; Qiu M
    BMJ Open; 2023 Dec; 13(12):e077974. PubMed ID: 38101828
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification and Analysis of Imaging-Genomic Signatures to Study Recurrence in breast cancers.
    Halder A; Bhowmick C; Dutta PK; Mahadevappa M
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083388
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An ensemble of bioinformatics and machine learning approaches to identify shared breast cancer biomarkers among diverse populations.
    Sultan G; Zubair S
    Comput Biol Chem; 2024 Feb; 108():107999. PubMed ID: 38070457
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay.
    Bernet-Vegué L; Cantero-González C; Sancho de Salas M; Parada D; Perin T; Quintero-Niño Z; Vieites Pérez-Quintela B; Sánchez-Guzmán D; Castelvetere M; Hardisson Hernaez D; Martín-Salvago MD
    Clin Transl Oncol; 2024 May; 26(5):1220-1228. PubMed ID: 38070048
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 42.